Page last updated: 2024-08-26

fibrinogen and Activated Protein C Resistance

fibrinogen has been researched along with Activated Protein C Resistance in 21 studies

Research

Studies (21)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	2 (9.52)	18.2507
2000's	12 (57.14)	29.6817
2010's	7 (33.33)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Akinci, E; Bodur, H; Dagdas, S; Eren, S; Onguru, P; Ozet, G; Yilmaz, M	1
Baghaei, F; Fagerberg Blixter, I; Gustafsson, KM; Hillarp, A; Lindahl, TL; Sten-Linder, M; Stigendal, L; Strandberg, K	1
Baghaei, F; Blixter, IF; Gustafsson, KM; Hillarp, A; Lindahl, TL; Sten-Linder, M; Stigendal, L; Strandberg, K	1
Bedi, VS; Mishra, MN	1
Duijkers, I; Junge, W; Klipping, C; Mellinger, U; Parke, S; Serrani, M	1
Brenner, B; Klein, E; Makhoul, B; Robicsek, O; Sarig, G	1
Burghardt, S; Giers, G; Handschel, J; Kübler, NR; Naujoks, C	1
De Staercke, C; Hooper, WC	1
Girolami, A; Paternoster, DM; Simioni, P; Snijders, D; Stella, A	1
Bałszan-Kowalska, I; Bińczak-Kuleta, A; Chełstowski, K; Ciechanowicz, A; Falkowski, A; Jastrzebska, M	1
Fijnheer, R; Probst, K; Rothova, A	1
Kapiotis, S; Katzenschlager, R; Miehsler, W; Novacek, G; Speiser, W; Vogelsang, H	1
Kapsoritakis, A; Kouroumalis, EA; Koutroubakis, IE; Maladaki, A; Manousos, ON; Mouzas, IA; Roussomoustakaki, M; Sfiridaki, A	1
Koh, SC; Prasad, RN; Ratnam, SS; Viegas, OA	1
Girolami, A; Patrassi, GM; Sartori, MT; Simioni, P; Theodoridis, P; Tormene, D	1
Anastasopoulou, J; Athanasiou, A; Karafoulidou, A; Kyriakidis, M; Terpos, E; Tsoukala, C	1
Biedermann, T; Flaig, MJ; Sander, CA	1
Ayhan, A; Baykal, C; Demirol, A; Kirazli, S	1
Mannucci, PM; Tripodi, A	1
Lowe, GD; Rumley, A; Rumley, J; Sweetnam, PM; Yarnell, JW	1
Di Micco, B; Di Micco, P; Federico, A; Niglio, A; Nozzolillo, P; Nunziata, L; Petronella, P; Romano, M; Torella, R	1

Reviews

2 review(s) available for fibrinogen and Activated Protein C Resistance

Article	Year
Venous thromboembolism: implications for gene-based diagnosis and technology development. Expert review of molecular diagnostics, 2002, Volume: 2, Issue:6 Topics: Activated Protein C Resistance; Blood Proteins; Disease Susceptibility; Epistasis, Genetic; Factor V; Female; Fibrinogen; Forecasting; Genetic Predisposition to Disease; Humans; Hyperhomocysteinemia; Male; Molecular Diagnostic Techniques; Neoplasms; Platelet Membrane Glycoproteins; Pregnancy; Pregnancy Complications, Hematologic; Prothrombin; Thromboembolism; Thrombophilia; Venous Thrombosis	2002
Laboratory investigation of thrombophilia. Clinical chemistry, 2001, Volume: 47, Issue:9 Topics: Activated Protein C Resistance; Antiphospholipid Syndrome; Antithrombins; Clinical Laboratory Techniques; Coronary Thrombosis; Factor V; Factor VIII; Fibrinogen; Humans; Hyperhomocysteinemia; Mutation; Protein C; Protein S; Prothrombin; Stroke; Thrombophilia; Venous Thrombosis	2001

Article

Year

Venous thromboembolism: implications for gene-based diagnosis and technology development.

Expert review of molecular diagnostics, 2002, Volume: 2, Issue:6

Topics: Activated Protein C Resistance; Blood Proteins; Disease Susceptibility; Epistasis, Genetic; Factor V; Female; Fibrinogen; Forecasting; Genetic Predisposition to Disease; Humans; Hyperhomocysteinemia; Male; Molecular Diagnostic Techniques; Neoplasms; Platelet Membrane Glycoproteins; Pregnancy; Pregnancy Complications, Hematologic; Prothrombin; Thromboembolism; Thrombophilia; Venous Thrombosis

2002

Laboratory investigation of thrombophilia.

Clinical chemistry, 2001, Volume: 47, Issue:9

Topics: Activated Protein C Resistance; Antiphospholipid Syndrome; Antithrombins; Clinical Laboratory Techniques; Coronary Thrombosis; Factor V; Factor VIII; Fibrinogen; Humans; Hyperhomocysteinemia; Mutation; Protein C; Protein S; Prothrombin; Stroke; Thrombophilia; Venous Thrombosis

2001

Trials

3 trial(s) available for fibrinogen and Activated Protein C Resistance

Article	Year
Hemostatic effects of a novel estradiol-based oral contraceptive: an open-label, randomized, crossover study of estradiol valerate/dienogest versus ethinylestradiol/levonorgestrel. Drugs in R&D, 2011, Volume: 11, Issue:2 Topics: Activated Protein C Resistance; Adolescent; Adult; Antigens; Antithrombin III; Blood Pressure; Contraceptives, Oral, Hormonal; Cross-Over Studies; Drug Combinations; Estradiol; Ethinyl Estradiol; Factor VII; Factor VIII; Female; Fibrin Fibrinogen Degradation Products; Fibrinogen; Hemostasis; Humans; Levonorgestrel; Middle Aged; Nandrolone; Patient Compliance; Peptide Fragments; Protein C; Protein Precursors; Protein S; Prothrombin; Sex Hormone-Binding Globulin; Young Adult	2011
Effects on hemostasis after two-year use of low dose combined oral contraceptives with gestodene or levonorgestrel. Clinical and applied thrombosis/hemostasis : official journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis, 1999, Volume: 5, Issue:1 Topics: Activated Protein C Resistance; Adolescent; Adult; Analysis of Variance; Antigens; Antithrombin III; beta-Thromboglobulin; Blood Platelets; Contraceptives, Oral, Synthetic; Factor VII; Female; Fibrin Fibrinogen Degradation Products; Fibrinogen; Hematocrit; Hemoglobins; Hemostasis; Humans; Levonorgestrel; Norpregnenes; Partial Thromboplastin Time; Peptide Fragments; Peptide Hydrolases; Plasminogen; Progesterone Congeners; Protein C; Protein S; Prothrombin; Thrombelastography; Time Factors; Tissue Plasminogen Activator; Urokinase-Type Plasminogen Activator; von Willebrand Factor	1999
Effects of hormone replacement on hemostasis in spontaneous menopause. Menopause (New York, N.Y.), 2001,Summer, Volume: 8, Issue:2 Topics: Activated Protein C Resistance; Adult; Antithrombin III; Blood Coagulation Factors; Double-Blind Method; Estrogen Replacement Therapy; Factor IX; Factor VIII; Female; Fibrinogen; Hemostasis; Humans; Lipoprotein(a); Medroxyprogesterone Acetate; Middle Aged; Partial Thromboplastin Time; Placebos; Prothrombin Time	2001

Other Studies

16 other study(ies) available for fibrinogen and Activated Protein C Resistance

Article	Year
Coagulopathy parameters in patients with Crimean-Congo hemorrhagic fever and its relation with mortality. Journal of clinical laboratory analysis, 2010, Volume: 24, Issue:3 Topics: Activated Protein C Resistance; Antithrombin III; Blood Coagulation Factors; Blood Coagulation Tests; Female; Fibrin Fibrinogen Degradation Products; Fibrinogen; Hemorrhage; Hemorrhagic Fever, Crimean; Humans; International Normalized Ratio; Male; Partial Thromboplastin Time; Platelet Count; Prognosis; Protein C; Protein S; Prothrombin Time; Risk Factors	2010
Effects of the oral, direct factor Xa inhibitor rivaroxaban on commonly used coagulation assays. Journal of thrombosis and haemostasis : JTH, 2011, Volume: 9, Issue:1 Topics: Activated Protein C Resistance; Administration, Oral; Adult; Anticoagulants; Antithrombins; Blood Coagulation; Blood Coagulation Tests; Dose-Response Relationship, Drug; Factor Xa Inhibitors; Female; Fibrinogen; Humans; Male; Morpholines; Partial Thromboplastin Time; Predictive Value of Tests; Prothrombin Time; Reproducibility of Results; Rivaroxaban; Thiophenes	2011
Effects of the oral, direct thrombin inhibitor dabigatran on five common coagulation assays. Thrombosis and haemostasis, 2011, Volume: 105, Issue:2 Topics: Activated Protein C Resistance; Administration, Oral; Adult; Aged; Antithrombins; Benzimidazoles; beta-Alanine; Blood Coagulation; Blood Coagulation Tests; Dabigatran; Dose-Response Relationship, Drug; Female; Fibrinogen; Humans; Male; Middle Aged; Partial Thromboplastin Time; Prothrombin Time; Reproducibility of Results; Thrombin	2011
Prevalence of common thrombophilia markers and risk factors in Indian patients with primary venous thrombosis. Sao Paulo medical journal = Revista paulista de medicina, 2010, Volume: 128, Issue:5 Topics: Activated Protein C Resistance; Adult; Biomarkers; Epidemiologic Methods; Female; Fibrinogen; Humans; India; Male; Middle Aged; Popliteal Vein; Protein S; Risk Factors; Thrombophilia; Venous Thrombosis; Young Adult	2010
Hypercoagulation in chronic post-traumatic stress disorder. The Israel Medical Association journal : IMAJ, 2011, Volume: 13, Issue:9 Topics: Activated Protein C Resistance; Adult; Biomarkers; Blood Coagulation Factors; Chronic Disease; Factor VIII; Fibrin Fibrinogen Degradation Products; Fibrinogen; Humans; Israel; Male; Peptide Fragments; Protein Precursors; Prothrombin; Stress Disorders, Post-Traumatic; Surveys and Questionnaires; Thrombophilia; Thromboplastin; von Willebrand Factor	2011
Parameters predicting complications in flap surgery. Oral surgery, oral medicine, oral pathology and oral radiology, 2013, Volume: 115, Issue:5 Topics: Activated Protein C Resistance; Blood Coagulation Tests; C-Reactive Protein; Factor VIII; Female; Fibrinogen; Follow-Up Studies; Forecasting; Free Tissue Flaps; Hematologic Tests; Hemorrhagic Disorders; Humans; Male; Necrosis; Plastic Surgery Procedures; Platelet Function Tests; Postoperative Complications; Postoperative Hemorrhage; Prospective Studies; Reoperation; Skin Transplantation; Surgical Flaps; Thrombophilia; Thrombosis; Venous Thrombosis; von Willebrand Factor	2013
Activated protein C resistance in normal and pre-eclamptic pregnancies. Gynecologic and obstetric investigation, 2002, Volume: 54, Issue:3 Topics: Activated Protein C Resistance; Adult; Antithrombin III; Case-Control Studies; Factor V; Female; Fibrinogen; Fibronectins; Haptoglobins; Humans; Italy; Partial Thromboplastin Time; Polymerase Chain Reaction; Pre-Eclampsia; Pregnancy; Pregnancy Trimesters; Prenatal Diagnosis; Prevalence; Prospective Studies; Prothrombin Time	2002
[Activated protein C resistance, Leiden mutation, anticoagulant proteins and fibrinogen levels in patients with deep venous thrombosis]. Polskie Archiwum Medycyny Wewnetrznej, 2003, Volume: 109, Issue:6 Topics: Activated Protein C Resistance; DNA Primers; Factor V; Female; Fibrinogen; Humans; Male; Middle Aged; Point Mutation; Venous Thrombosis	2003
Endothelial cell activation and hypercoagulability in ocular Behçet's disease. American journal of ophthalmology, 2004, Volume: 137, Issue:5 Topics: Activated Protein C Resistance; Adult; Antigens; Antithrombin III; Behcet Syndrome; Cross-Sectional Studies; Endothelium, Vascular; Factor VIII; Female; Fibrinogen; Humans; Male; Middle Aged; Prospective Studies; Protein C; Protein S; Ristocetin; Thrombophilia; Venous Thrombosis; von Willebrand Factor	2004
Thromboembolism and resistance to activated protein C in patients with inflammatory bowel disease. The American journal of gastroenterology, 1999, Volume: 94, Issue:3 Topics: Activated Protein C Resistance; Adolescent; Adult; Aged; Antithrombin III; C-Reactive Protein; Female; Fibrinogen; Humans; Inflammatory Bowel Diseases; Male; Middle Aged; Risk Factors; Thromboembolism	1999
Resistance to activated protein C and low levels of free protein S in Greek patients with inflammatory bowel disease. The American journal of gastroenterology, 2000, Volume: 95, Issue:1 Topics: Activated Protein C Resistance; Adult; Antithrombin III; Female; Fibrinogen; Humans; Inflammatory Bowel Diseases; Male; Middle Aged; Protein C; Protein S; Thrombophilia	2000
Combined heterozygous plasminogen deficiency and factor V Leiden defect in the same kindred. Clinical and applied thrombosis/hemostasis : official journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis, 2000, Volume: 6, Issue:1 Topics: Activated Protein C Resistance; Adult; Aged; Antibodies, Antiphospholipid; Antithrombins; Factor V; Family Health; Female; Fibrinogen; Fibrinolytic Agents; Genotype; Heterozygote; Humans; Lupus Coagulation Inhibitor; Male; Middle Aged; Partial Thromboplastin Time; Pedigree; Plasminogen; Point Mutation; Protein C; Protein S; Prothrombin; Prothrombin Time	2000
Thrombophilic factors in patients with Syndrome X. Thrombosis research, 2000, Mar-15, Volume: 97, Issue:6 Topics: Activated Protein C Resistance; Antithrombin III; Blood Coagulation Factors; Case-Control Studies; Enzyme-Linked Immunosorbent Assay; Factor VII; Factor VIII; Female; Fibrinogen; Humans; Male; Microvascular Angina; Middle Aged; Plasminogen; Plasminogen Activator Inhibitor 1; Protein C; Protein S; Risk Factors; Thrombosis; Tissue Plasminogen Activator; von Willebrand Factor	2000
Livedoid vasculopathy in a patient with factor V mutation (Leiden). Journal of cutaneous pathology, 2000, Volume: 27, Issue:8 Topics: Activated Protein C Resistance; Antibodies, Antineutrophil Cytoplasmic; Blood Vessels; Complement C3; DNA; Factor V; Female; Fibrinogen; Fluorescent Antibody Technique, Direct; Humans; Immunoglobulin M; Leg Ulcer; Middle Aged; Point Mutation; Polymerase Chain Reaction; Skin; Skin Diseases, Vascular; Vasculitis	2000
Fibrin D-dimer, markers of coagulation activation and the risk of major ischaemic heart disease in the caerphilly study. Thrombosis and haemostasis, 2001, Volume: 86, Issue:3 Topics: Activated Protein C Resistance; Antigens; Antithrombin III; Biomarkers; Blood Coagulation; Cohort Studies; Disease Susceptibility; Factor VII; Female; Fibrin Fibrinogen Degradation Products; Fibrinogen; Humans; Incidence; Male; Middle Aged; Myocardial Ischemia; Northern Ireland; Odds Ratio; Partial Thromboplastin Time; Peptide Fragments; Peptide Hydrolases; Predictive Value of Tests; Prothrombin	2001
Alteration of haemostasis in non-metastatic gastric cancer. Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver, 2001, Volume: 33, Issue:7 Topics: Activated Protein C Resistance; Case-Control Studies; Female; Fibrin Fibrinogen Degradation Products; Fibrinogen; Fibrinolysis; Hemostasis; Humans; Male; Middle Aged; Partial Thromboplastin Time; Prothrombin Time; Stomach Neoplasms; Thrombin; Thromboembolism; Tissue Plasminogen Activator	2001